Members
Jumee Kim, Ph.D.
-
Reprogramming for tissue regeneration
-
Disease modeling using PSCs
-
Disease modeling for genetic disorder research
-
In vivo gene/cell therapy
-
Distinctive characteristic of ferroptosis in stem cells
Yun-Jeong Kim, Ph.D.
-
YAP1/TAZ/TEAD signaling in PSCs
-
Genetic alterations and Heterogeneity of PSCs, Ferroptosis regulation in PSCs
-
Precise genome editing in PSCs
Seung-Yeon Lee,
Ph.D. candidate
sylee3026@gmail.com
-
In vivo reprogramming in small intestine
-
Disease modeling and gene editing
-
Stem cell Ageing in small intestine
-
Cell signaling in chemoresistance of cancer cell and pathogenicity of ‘Disease-in-a-Dish’ from human PSCs
-
Leveraging Data-Driven Approaches for Predicting Drug Mode of Action (MOA) and in vitro Validation
-
Prediction of phenotype signatures from public database
-
Molecular mechanism of liver regeneration
-
Epigenetic regulation upon cellular dedifferentiation
-
Development of regenerative medicine
-
Disease modeling and drug discovery by using gene editing tools with PSCs.
-
Finding a new therapeutic strategy for genetic disease.
-
DNA damage repair and Cas9 gene editing
-
Epigenetic regulation in totipotent/ PSCs
-
Distinct Iron Metabolism in PSCs
-
Hair graying in OSKM mice
-
Reprogramming mechanisms in hepatic disease conditions
-
Signaling pathway in intestinal stem cells
